| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 04/23/2013 | CA2653552C Industrial process for the synthesis of 17.alpha.-acetoxy-11.beta.-[4-(n,n-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 04/03/2013 | CN103012540A 22-drop-6-hydroxystigmast-3,22-O-dimethyloxime ether and 22-drop-6-oximido-stigmast-3,22-O-dimethyloxime ether and application thereof to preparation of antitumor drugs |
| 04/03/2013 | CN103012539A Method for producing tauro-ursodesoxycholic acid with 98.5 percent ursodesoxycholic acid |
| 04/03/2013 | CN103012538A Glycocholic acid refining method |
| 03/21/2013 | US20130072464 Progesterone receptor antagonists |
| 03/14/2013 | WO2013036835A1 Neuroactive steroids, compositions, and uses thereof |
| 03/14/2013 | US20130066086 Nanoparticle peg modification with h-phosphonates |
| 03/14/2013 | US20130065325 Zwitterionic reagents |
| 03/14/2013 | CA2848212A1 Neuroactive steroids, compositions, and uses thereof |
| 03/13/2013 | CN102964419A Preparation method of compound dienogest |
| 03/07/2013 | WO2013030410A2 Synthesis of abiraterone and related compounds |
| 03/06/2013 | CN102952168A Estrogen derivative used as vasoinhibitor, as well as preparation method and medical application thereof |
| 02/28/2013 | WO2013027073A1 Histamine h3 antagonist steroidal carboxamides |
| 02/28/2013 | US20130053507 Hydrophobic ceragenin compounds and devices incorporating same |
| 02/27/2013 | EP2560984A2 Process for the preparation of dienogest substantially free of impurities |
| 02/27/2013 | CN102942612A Novel method for synthesizing ulipristal acetate |
| 02/20/2013 | CN102936273A Novel azobenzene derivative, and preparation method and application thereof |
| 02/14/2013 | US20130041166 Process for the preparation of dienogest substantially free of impurities |
| 02/05/2013 | US8367315 Inactivation of reverse transcriptases by azido-diarylpyrimidines |
| 01/31/2013 | WO2013016725A1 Progesterone antagonists |
| 01/31/2013 | WO2013013595A1 Crystal of 17α-acetoxy-11β-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-dien- 3,20-dione and preparation process thereof |
| 01/31/2013 | WO2013013594A1 Amorphous substance of 17α-acetoxy-11β-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione and preparation method thereof |
| 01/31/2013 | US20130029953 Progesterone antagonists |
| 01/31/2013 | US20130029901 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 01/31/2013 | CA2846573A1 Progesterone antagonists |
| 01/30/2013 | EP2550288A1 Compositions and methods for non-toxic delivery of antiprogestins |
| 01/30/2013 | CN102906103A Compositions and methods for non-toxic delivery of antiprogestins |
| 01/29/2013 | US8361996 Imidazolyl substituted steroidal and indan-1-one derivatives |
| 01/23/2013 | CN102887931A Ulipristal acetate crystals and preparation method thereof |
| 01/22/2013 | CA2683522C 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 01/17/2013 | US20130018027 Compositions and methods for non-toxic delivery of antiprogestins |
| 01/16/2013 | CN102875629A Synthetic method of ulipristal acetate |
| 01/15/2013 | US8354395 Method for providing neuroprotection from spinal muscular atrophy |
| 01/09/2013 | CN102219822B Ganoderic acid T amide derivative TLTO-A and synthetic method and application thereof |
| 01/03/2013 | US20130005696 Bufadienolide derivatives, preparing process thereof, composition comprising the same and the use thereof |
| 01/03/2013 | US20130004425 Biomineral and Metal Binding Liposomes, Their Synthesis, and Methods of Use Thereof |
| 01/02/2013 | CN102850426A A glucocorticoid with 21 site N-acetylcystein ester |
| 12/19/2012 | EP2534167A2 Progesterone receptor antagonists |
| 12/19/2012 | EP2534166A2 Progesterone receptor antagonists |
| 12/19/2012 | CN102834405A Progesterone receptor antagonists |
| 12/18/2012 | CA2626627C Androsterone derivatives and method of use thereof |
| 12/18/2012 | CA2519956C Compound |
| 12/12/2012 | CN102816198A Preparation method of 3-hydroxy-5-alkenesteroid compounds with ammonia derivative branched chain structure and application thereof in antineoplastic drugs |
| 12/12/2012 | CN102813659A Use of 20alpha-dimethylamino-2alpha-hydroxy-3beta-tiropramide-5alpha-pregnane |
| 12/05/2012 | CN102812035A Methods For The Purification Of Deoxycholic Acid |
| 12/05/2012 | CN101817860B Synthetic method of 13C marked glycocholic acid |
| 11/28/2012 | EP2527355A2 Polymorphic and amorphous salt forms of squalamine dilactate |
| 11/28/2012 | CN102796160A 17ss-hsd1 and sts inhibitors |
| 11/14/2012 | CN102772419A Application of sarcococca vegans alkaline D |
| 11/14/2012 | CN102772418A Application of pachysamine/pachysandrine G |
| 11/08/2012 | US20120283450 Compounds including an anti-inflammatory pharmacore and methods of use |
| 11/08/2012 | US20120283217 Modulators of amyloid-beta production |
| 11/07/2012 | CN102766188A Cholesterol derivative, chelate, recombinant high density lipoprotein and application thereof |
| 11/01/2012 | US20120277448 Preparation method for 3beta-arachidylamido-7alpha, 12alpha, 5beta-cholan-24-carboxylic acid |
| 10/31/2012 | CN101861327B An amorphous form of an anti-inflammatory compound |
| 10/30/2012 | CA2669355C Guggulphospholipid methods and compositions |
| 10/24/2012 | EP2513132A2 Methods for the purification of deoxycholic acid |
| 10/24/2012 | CN102753565A Progesterone receptor antagonists |
| 10/18/2012 | US20120264810 Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles |
| 10/10/2012 | EP2507253A2 6-substituted estradiol derivatives and methods of use |
| 10/10/2012 | CN102718829A Method for preparing sodium tauroursodeoxycholate |
| 10/10/2012 | CN102718828A Preparation method for dienogest |
| 10/09/2012 | US8283341 Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process |
| 10/03/2012 | CN102702556A Ultraviolet-assisted surface modification method and product with surface formed thereby |
| 10/03/2012 | CN102079771B Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof |
| 10/03/2012 | CN101891791B Derivate for labeling bile acid and reference compound, preparation method and application thereof |
| 09/20/2012 | US20120238488 Compounds and methods for treating neoplasia |
| 09/19/2012 | CN102675673A Ultraviolet ray assisted surface modification method and product with surface formed thereby |
| 09/19/2012 | CN102675672A Ultraviolet aided surface modification method and product with surface formed by method |
| 09/19/2012 | CN102675400A 3, 16 beta-diamido-steroid quaternary ammonium salt derivatives, and preparation method and application thereof |
| 09/18/2012 | CA2516319C Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
| 09/13/2012 | WO2011075701A4 Methods for the purification of deoxycholic acid |
| 09/12/2012 | CN102659895A Steroid alkaloid hydrochloride, its preparation method and application |
| 09/12/2012 | CN102659894A Hexose ester, synthetic method thereof and use thereof |
| 09/12/2012 | CN101189251B 17 beta-HSD1 and STS inhibitors |
| 09/05/2012 | CN102656179A Bufalin derivatives, pharmaceutical compositions and use thereof |
| 09/05/2012 | CN102286053B Pregnenolone pyrrole compound and preparation method thereof |
| 09/05/2012 | CN101622268B Industrial method for the synthesis of 17-acetoxy-11beta-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process |
| 08/23/2012 | WO2012110010A1 Pregnanolone derivatives substituted in 3alpha-position with the cationic group, method of their production, usage and pharmaceutical preparation involving them |
| 08/16/2012 | WO2012109275A1 Methods and systems for determining the presence or amount of delta 5 steroid compounds in a sample |
| 08/15/2012 | EP2485770A2 Novel cationic lipids with short lipid chains for oligonucleotide delivery |
| 08/15/2012 | CN102634334A Pyrene-dicholesterol-containing fluorescent probe, as well as synthetic method and application thereof |
| 08/09/2012 | WO2012047495A3 Methods for preparing synthetic bile acids and compositions comprising the same |
| 08/09/2012 | US20120202890 Polymer-carbohydrate-lipid conjugates |
| 08/08/2012 | CN102002085B Method for preparing epristeride |
| 07/31/2012 | CA2703688C Use of bile acid or bile salt fatty acid conjugates |
| 07/26/2012 | WO2011075701A3 Methods for the purification of deoxycholic acid |
| 07/26/2012 | US20120190659 Angiogenesis inhibitors |
| 07/26/2012 | US20120190635 Selective oxidation of c-h bonds of modified substrates by p450 monooxygenase |
| 07/26/2012 | US20120189571 Nanoscale platinum compounds and methods of use thereof |
| 07/18/2012 | CN102584926A Method for preparing supermolecule hydrogel based on amphiphilic micromolecules (cholesterol and phosphorylcholine) |
| 07/04/2012 | CN102532236A Steroid 5Alpha-reductase inhibitors, preparation methods thereof and medical applications thereof |
| 06/27/2012 | EP2111409B1 Novel cationic 17 alpha- substituted-estradiol derivatives useful as anti-cancer agent |
| 06/27/2012 | CN102516346A Organic micromolecule gel factor and application thereof |
| 06/27/2012 | CN102516345A Preparation method of ulipristal acetate and key intermediate thereof |
| 06/21/2012 | US20120157421 17Beta-Alkyl-17Alpha-oxy-estratrienes |
| 06/21/2012 | US20120157419 Methods and compositions for treating alzheimer's disease |
| 06/14/2012 | WO2012051988A3 Derivatives of steroid benzylamines, having an antiparasitic, antibacterial, antimycotic and/or antiviral action |
| 06/14/2012 | US20120149670 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases |
| 06/13/2012 | EP2462154A2 Novel crystal form of cdb-4124 and process for the preparation thereof |